Related Experiment Video
Updated: Nov 18, 2025

07:12
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
Published on: October 26, 2017
8.0K
Fine-Feature Modifications to Strained Ruthenium Complexes Radically Alter Their Hypoxic Anticancer Activity†.
Houston D Cole1, John A Roque1,2, Liubov M Lifshits1
1Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, TX, USA.
Photochemistry and Photobiology
|February 9, 2021
Summary
Minor structural changes in ruthenium complexes significantly alter their photochemotherapy effectiveness. Functionalization impacts activity differently between isomers, highlighting the sensitivity of these compounds to subtle modifications.
Area of Science:
- Medicinal Chemistry
- Photodynamic Therapy
- Ruthenium Complexes
Background:
- Earlier studies revealed significant biological activity differences between structural isomers of π-expansive ruthenium complexes.
- These complexes are investigated for photodynamic and photochemotherapy applications.
Purpose of the Study:
- To explore the activity of functionalized derivatives of previously studied ruthenium complex isomers.
- To investigate the impact of structural modifications on photocytotoxicity under normoxic and hypoxic conditions.
Main Methods:
- Synthesis and testing of functionalized derivatives of 1-NIP and 2-NIP ruthenium isomers.
- Evaluation of photocytotoxicity under normoxic and hypoxic conditions.
- Measurement of singlet oxygen sensitization quantum yield and photosubstitution rates.
Main Results:
- Functionalization with methyl or methoxy groups restored photocytotoxicity to the inactive 2-NIP isomer.
- Methoxy variants of the active 1-NIP isomer became inactive.
- Singlet oxygen sensitization quantum yield remained below 1% for all compounds.
- Hypoxic photocytotoxicity was generally attenuated, with few active compounds.
Conclusions:
- Minor structural modifications on non-strained ligands dramatically modulate the normoxic and hypoxic activity of strained ruthenium complexes.
- These structural changes influence photocytotoxicity more than singlet oxygen sensitization or photosubstitution rates in cell-free conditions.
More Related Videos
Related Concept Videos
Cancer Therapies
9.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
Electron Transport Chain: Complex I and II
17.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.0K

